Integrating genomic features for non-invasive early lung cancer detectionJacob J. Chabon, Maximilian Diehn, Joseph G. Schroers‐Martin et al.|Nature|2020Cited by 689
Noninvasive Early Identification of Therapeutic Benefit from Immune Checkpoint InhibitionBarzin Y. Nabet, Maximilian Diehn, Mohammad Shahrokh Esfahani et al.|Cell|2020Cited by 360
<i>KEAP1/NFE2L2</i> Mutations Predict Lung Cancer Radiation Resistance That Can Be Targeted by Glutaminase InhibitionMichael S. Binkley, Maximilian Diehn, Young-Jun Jeon et al.|Cancer Discovery|2020Cited by 172